Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines

Draft Guidance for Industry: Postmarketing Safety Reporting for Human Drug and Biological Products Including Vaccines, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2Zghta9